BEIJING, China, Aug. 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China’s new energy vehicle market, today announced that it delivered 30,468 vehicles in July 2026. As of July 31, 2026, Li Auto’s cumulative deliveries reached 1,764,155. In July 2026, the Company launched the new Li L6, while cumulative deliveries of Li L9 surpassed 300,000 units. On July 15, the Company introduced the all-new Li L9 to Kazakhstan and commenced localized production. A late-July OTA update for 2026 models also upgraded intelligent assisted driving capabilities, further elevating the user experience. As of July 31, 2026, the Company had 490 reta
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Li Auto Inc. July 2026 Delivery Update
- Nexstar Media Group Declares Quarterly Cash Dividend of $1.86 Per Share
Nexstar Media Group, Inc. (NASDAQ:NXST) announced today that its Board of Directors declared a quarterly cash dividend of $1.86 per share of its common stock. The dividend is payable on Friday, August 28, 2026, to shareholders of record on Friday, August 14, 2026. While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its discretion, including future increases. About Nexstar Media Group, Inc. Nexstar Media Group, Inc. (NASDAQ:NXST) is a leading diversified media company that produces and distributes engaging local and national news, sports and entertainm
- Anfield Energy Closes US$6.9 million Underwritten Public Offering
VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. ("Anfield" or the "Company") (TSX.V: AEC, NASDAQ:AEC, FRANKFURT: 0AD) has closed its previously announced underwritten public offering (the "Offering") of 1,715,000 common shares (the "Common Shares"), which includes the full exercise of the underwriters’ option to purchase an additional 233,695 Common Shares, at a price of US$4.00 per Common Share for aggregate gross proceeds to the Company of US$6.9 million. The Offering was conducted through a syndicate of underwriters led by Northland Capital Markets and Roth Capital Partners as joint bookrunners, pursuant to an underwriting agreement dated July 30, 202
- Pacific Gas and Electric Company Announces Results of Cash Tender Offers
OAKLAND, Calif., July 31, 2026 /PRNewswire/ -- Pacific Gas and Electric Company (the "Company") today announced the results of its previously announced cash tender offers ( "Tender Offers") to purchase up to an aggregate principal amount that will not result in an aggregate purchase price that exceeds $1,200,000,000 (the "Aggregate Maximum Tender Amount") of its outstanding 3.30% Senior Notes due December 1, 2027 (the "3.30% Senior Notes") and 2.10% First Mortgage Bonds due August 1, 2027 (the "2.10% First Mortgage Bonds", and, together with the 3.30% Senior Notes, the "Bonds" and, each series, a "series of Bonds"), upon the terms and subject to the conditions set forth in the Offer to Purch
- Avista Makes Annual Price Adjustment Filings in Idaho
SPOKANE, Wash., July 31, 2026 (GLOBE NEWSWIRE) -- Avista (NYSE:AVA) has made annual filings with the Idaho Public Utilities Commission (IPUC or Commission) that have no impact on Avista’s earnings. These filings seek to true-up the level of costs in customer rates with the actual level incurred by the Company. Natural Gas Adjustment FilingsThe Company filed three annual natural gas requests that, if approved, would update natural gas rates starting November 1, 2026 as shown below: Purchased Gas Cost Adjustment (PGA): a decrease of approximately $2.5 million or 3.0%Fixed Cost Adjustment (FCA): an increase of approximately $2.4 million or 2.8%Natural Gas Energy Efficiency Adjustment: a dec
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (NASDAQ:CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced that, on July 30, 2026, CareDx granted to James McNally, the Company’s newly appointed Executive Advisor, certain stock awards as an inducement material to Mr. McNally’s employment with CareDx. CareDx granted 15,822 shares of common stock restricted stock units (RSUs) to Mr. McNally. The RSU awards were made pursuant to the Company’s 2025 Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). 50% of the RSUs will vest on January 2, 2027, and 50% will vest on July 2, 2027 subject to the employee’s continued service
- SABA Announces Notification of Sources of Distributions
Saba Capital Income & Opportunities Fund II (NYSE:SABA) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be
- BRW Announces Notification of Sources of Distributions
Saba Capital Income & Opportunities Fund (NYSE:BRW) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be paid
- BrilliA Incorporated Reports Fiscal Year 2026 Financial Results
Generated positive operating cash flow, returned $3.3 million to shareholders via dividends, maintained a debt-free balance sheet, and expects return to growth in fiscal 2027 on strengthening sales pipeline and brand portfolio expansion BrilliA Incorporated (NYSE:BRIA) ("BrilliA" or the "Company") today reported financial results for its fiscal year ended March 31, 2026. Fiscal Year 2026 Highlights Return to growth underway in fiscal 2027: Based on preliminary unaudited results for the first quarter ended June 30, 2026, revenue increased approximately 13% year-over-year, and the Company currently expects second-quarter revenue to increase approximately 30% year-over-year. Generate
- Ferguson Enterprises Set to Join S&P 500 and ADI Global Distribution to Join S&P SmallCap 600
NEW YORK, July 31, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600: Ferguson Enterprises Inc. (NYSE: FERG) will replace Electronic Arts Inc. (NASD: EA) in the S&P 500 effective prior to the opening of trading on Wednesday, August 5. An investor consortium comprised of Public Investment Fund, Silver Lake, and Affinity Partners are acquiring Electronic Arts in a deal expected to be completed soon, pending final conditions.ADI Global Distribution Inc. (NYSE:ADIG) will be added to the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, August 4, replacing Hertz Global Holdings Inc. (NASD: HTZ) in the S&P SmallCap
- FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
- First patients dosed in phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers- On track for interim results reporting in 2H 2026HOUSTON, July 31, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today reported financial results for the second quarter ended June 30, 2026, and provided a corporate update. Recent Highlights:Clinical Updates:Initiation of patient dosing in the
- First Horizon Recognized With Two Newsweek Awards for Second Consecutive Year
MEMPHIS, Tenn., July 31, 2026 /PRNewswire/ -- First Horizon Corporation (NYSE:FHN) is proud to be recognized with two Newsweek awards for the second year in a row. The company earned honors as one of America's Greatest Workplaces in Financial Services and as one of America's Greatest Workplaces for Women. The first recognition, for Financial Services, highlights U.S. financial services employers based on 10 dimensions of associate satisfaction, using 220,000+ reviews gathered between April and October 2025 and weighted results from studies conducted between 2022 and 2024. As the sector evolves and continues to be driven by fint
- Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
BERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of an Option Agreement (the "Agreement") which provides Profusa the right and option, but not the obligation, subject to satisfaction of the conditions described below, to acquire G3 Vision Labs, Inc. ("G3") and its subsidiaries, Med Screen Laboratories Inc., Dominion Diagnostics LLC and Acutis Diagnostics Inc. G3's 2025 Net Revenues are estimated, based on unaudited management information, to be approximately $111 million. The Agreement formalizes the arrangement between Profusa and G3 that was announced earlie
- Caliber Sets Date for Second Quarter 2026 Earnings Announcement & Investor Conference Call
SCOTTSDALE, Ariz., July 31, 2026 (GLOBE NEWSWIRE) -- Caliber (Nasdaq CWD), a diversified real estate and digital asset management platform, today announced that it will release its second quarter 2026 financial results after the close of the stock market on Thursday, August 13, 2026. Management invites all interested parties to its webcast/conference call the same day at 5:00 pm ET to discuss the results. Investors and interested parties can access the live earnings call by dialing (800) 715-9871 (domestic) or (646) 307-1963 (international) and ask to join the Caliber call or use conference ID 9678789. To listen to the call online, investors can visit the investor relations page of Calib
- Sun Life Appoints Katherine Lee to Board of Directors
TORONTO, July 31, 2026 /CNW/ -- Sun Life Financial Inc. (TSX:SLF) (NYSE:SLF) is pleased to announce the appointment of Katherine Lee to the Sun Life Board of Directors, effective July 31, 2026.Ms. Lee is a seasoned executive and board director with deep experience in financial services, investments and real estate. Her various senior management roles combined with her over 20 years of public and private board service have contributed to her talent for navigating organizational and regulatory complexity, particularly during periods of transformation. She will bring valuable perspective to Sun Life's Board as the company continues to advance its strategic priorities and deliver long-term value
- Uni-Fuels Announces Receipt of Nasdaq Notification Letter Regarding Minimum Price Deficiency
SINGAPORE, July 31, 2026 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited ("Uni-Fuels" or the "Company") (NASDAQ:UFG), a global provider of marine fuel solutions headquartered in Singapore, today announced that it received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") dated July 27, 2026, notifying the Company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s class A ordinary shares was below $1 per share for the last 30 consecutive business days (i.e. from June 11, 2026 to July 24, 2026). The Nasdaq Letter is only a notif
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced the granting of inducement awards to five new non-executive employees as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Company through the applicable vesting date, and the
- XORTX Announces Director Resignation
CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that Anthony Giovinazzo is stepping down from the board of directors for personal reasons and to pursue other interests. Dr. Allen Davidoff, co-CEO of XORTX, stated, "XORTX management and the board of directors extends our heartfelt appreciation for Mr. Giovinazzo’s efforts as chairman of the board during the past several years. Anthony’s contribution to XORTX spans leadership and ethics of the highest s
- Volaris Announces the Release of the 2025 Integrated Annual Report
MEXICO CITY, July 31, 2026 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS, BMV:VOLAR) ("Volaris" or "the Company"), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, today released its 2025 Integrated Annual Report, titled "Ready for what’s next." The 2025 Integrated Annual Report is now available on Volaris' Investor Relations webpage: https://ir.volaris.com/. Investor Relations ContactLiliana Juárez / ir@volaris.com Media ContactRicardo Flores / rflores@gcya.net The information included in this report has not been audited and does not provide any information about the Company's future performance. V
- DXP Enterprises, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
DXP Enterprises, Inc. (the "Company") (NASDAQ:DXPE), a leading business to business products and service distributor that adds value and total cost savings solutions to MRO and OEM customers in virtually every industry, plans to issue a press release announcing its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5th after the market closes. DXP will host a conference call, to be web cast live, on the Company’s website (www.dxpe.com) at 10:30 AM Central Time on Thursday, August 6th. The call and an accompanying slide presentation will be on the "Investor Relations" section of DXP's website at www.dxpe.com. A replay of the webcast will be available shortly